US 11129826
Bupropion as a modulator of drug activity
granted A61KA61K31/135A61K31/137
Quick answer
US patent 11129826 (Bupropion as a modulator of drug activity) held by AXSOME THERAPEUTICS, INC. expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AXSOME THERAPEUTICS, INC.
- Grant date
- Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/135, A61K31/137, A61K31/15, A61K31/343